On January 22, 2026, IQVIA Holdings Inc. (NYSE:IQV), a globally recognized provider of clinical research services and healthcare intelligence, proudly announced its position as the number one company in the Health Care: Pharmacy and Other Services category on the *Fortune*® World’s Most Admired Companies™ list. This prestigious accolade marks the fifth consecutive year that IQVIA has claimed the top spot in its sector, solidifying its reputation as a leader in the healthcare industry.

2. A Testament to Corporate Excellence

This year’s recognition also highlights IQVIA’s impressive consistency; it has made the *Fortune*® list for nine straight years. The company's remarkable performance can be attributed to its exceptional ratings across seven out of nine key attributes assessed in the survey. These attributes include innovation, people management, financial soundness, and global competitiveness, demonstrating IQVIA’s strength in multiple facets of its business operations.

Ari Bousbib, IQVIA’s Chairman and CEO, expressed pride in the recognition, stating, “This recognition reflects the unwavering dedication and expertise of our employees worldwide. Their commitment to advancing innovation and improving global health supports the development of transformative medical treatments that enhance patient outcomes around the world.” His remarks underscore the important role of the company’s workforce in achieving this esteemed recognition.

3. Insights Into the Survey Methodology

The *Fortune*® World’s Most Admired Companies™ list serves as a definitive report card on corporate reputations, established since 1997. The annual survey, conducted in collaboration with Korn Ferry—a global organizational consulting firm—analyzes 685 companies and surveys over 3,000 executives, directors, and financial analysts to measure corporate reputation based on various attributes.

The evaluation focuses on a comprehensive set of criteria, including effectiveness in global business operations, talent attraction and retention, long-term investment value, and social responsibility, providing a well-rounded view of a company's standing within its industry and beyond.

4. IQVIA's Commitment to Excellence

IQVIA is not only a leader in providing clinical research services but also a pioneer in employing advanced technologies to drive healthcare solutions. With approximately 91,000 employees in over 100 countries, the company leverages its extensive expertise in healthcare, life sciences, and data science to deliver actionable insights and innovative services. Their commitment to responsible use of artificial intelligence and adherence to privacy standards further enhances their reputation as a trusted partner in the healthcare industry.

In a rapidly evolving landscape, IQVIA continues to focus on improving patient outcomes and advancing population health through its robust portfolio of AI-powered capabilities, advanced analytics, and a deep understanding of disease patterns.

5. Conclusion

IQVIA's recognition as the most admired company in its sector for the fifth consecutive year underscores its unwavering commitment to excellence, innovation, and corporate responsibility. As the healthcare landscape continues to evolve, IQVIA remains a steadfast leader, dedicated to transforming healthcare through data-driven insights and innovative medical solutions. This accolade not only reflects the company’s past achievements but also sets the stage for its ongoing mission to enhance global health outcomes.

Original press release